These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 12750298)
1. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2. Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298 [TBL] [Abstract][Full Text] [Related]
2. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations. Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491 [TBL] [Abstract][Full Text] [Related]
3. Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption. Meyer S; Fergusson WD; Whetton AD; Moreira-Leite F; Pepper SD; Miller C; Saunders EK; White DJ; Will AM; Eden T; Ikeda H; Ullmann R; Tuerkmen S; Gerlach A; Klopocki E; Tönnies H Genes Chromosomes Cancer; 2007 Apr; 46(4):359-72. PubMed ID: 17243162 [TBL] [Abstract][Full Text] [Related]
4. Biallelic inactivation of BRCA2 in Fanconi anemia. Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746 [TBL] [Abstract][Full Text] [Related]
5. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2. Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162 [TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia with complex hypodiploidy and loss of heterozygosity of 17p in a boy with Fanconi anemia. Woo HI; Kim HJ; Lee SH; Yoo KH; Koo HH; Kim SH Ann Clin Lab Sci; 2011; 41(1):66-70. PubMed ID: 21325258 [TBL] [Abstract][Full Text] [Related]
8. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations. Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014 [TBL] [Abstract][Full Text] [Related]
9. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460 [TBL] [Abstract][Full Text] [Related]
10. Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1. Navarro S; Meza NW; Quintana-Bustamante O; Casado JA; Jacome A; McAllister K; Puerto S; Surrallés J; Segovia JC; Bueren JA Mol Ther; 2006 Oct; 14(4):525-35. PubMed ID: 16859999 [TBL] [Abstract][Full Text] [Related]
11. Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia. Meyer S; Barber LM; White DJ; Will AM; Birch JM; Kohler JA; Ersfeld K; Blom E; Joenje H; Eden TO; Malcolm Taylor G Br J Haematol; 2006 May; 133(3):284-92. PubMed ID: 16643430 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-2-induced graft-versus-leukemia for the treatment of AML in a BRCA2 Fanconi anemia patient. Yeo CJ; Gilman AL J Pediatr Hematol Oncol; 2014 Mar; 36(2):e78-80. PubMed ID: 23619121 [TBL] [Abstract][Full Text] [Related]
13. RUNX1 amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to acute myelogenous leukemia. Podgornik H; Debeljak M; Zontar D; Cernelc P; Prestor VV; Jazbec J Cancer Genet Cytogenet; 2007 Oct; 178(1):77-81. PubMed ID: 17889714 [TBL] [Abstract][Full Text] [Related]
14. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia. Venkatraj VS; Gaidano G; Auerbach AD Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N; Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169 [TBL] [Abstract][Full Text] [Related]
16. p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. Rosselli F; Ridet A; Soussi T; Duchaud E; Alapetite C; Moustacchi E Oncogene; 1995 Jan; 10(1):9-17. PubMed ID: 7824283 [TBL] [Abstract][Full Text] [Related]
17. Fanconi anemia gene mutations are not involved in sporadic Wilms tumor. Adank MA; Segers H; van Mil SE; van Helsdingen YM; Ameziane N; van den Ouweland AM; Wagner A; Meijers-Heijboer H; Kool M; de Kraker J; Waisfisz Q; van den Heuvel-Eibrink MM Pediatr Blood Cancer; 2010 Oct; 55(4):742-4. PubMed ID: 20589654 [TBL] [Abstract][Full Text] [Related]
18. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development. Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604 [TBL] [Abstract][Full Text] [Related]
19. Hepatoblastoma in a 4-year-old girl with Fanconi anaemia. Kopic S; Eirich K; Schuster B; Hanenberg H; Varon-Mateeva R; Rittinger O; Schimpl G; Schindler D; Jones N Acta Paediatr; 2011 May; 100(5):780-3. PubMed ID: 21138478 [TBL] [Abstract][Full Text] [Related]
20. Fanconi anemia revisited: old ideas and new advances. dos Santos CC; Gavish H; Buchwald M Stem Cells; 1994 Mar; 12(2):142-53. PubMed ID: 8199559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]